These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21329423)

  • 1. Biological models of breast cancer: one size does not fit all.
    Choong LY; Lim YP
    Expert Rev Proteomics; 2011 Feb; 8(1):5-7. PubMed ID: 21329423
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of PI3K and MEK: it is all about combinations and biomarkers.
    Rexer BN; Ghosh R; Arteaga CL
    Clin Cancer Res; 2009 Jul; 15(14):4518-20. PubMed ID: 19584146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast cancer and molecular markers].
    Ishioka C
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1261-8. PubMed ID: 18701834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic biomarkers and breast cancer: cause for optimism.
    Visvanathan K; Sukumar S; Davidson NE
    Clin Cancer Res; 2006 Nov; 12(22):6591-3. PubMed ID: 17121875
    [No Abstract]   [Full Text] [Related]  

  • 5. HER2 signatures in breast cancer: ready to go to print?
    Eichhorn PJ; Baselga J
    J Clin Oncol; 2010 Apr; 28(11):1809-10. PubMed ID: 20231675
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.
    Pan Q; Bao LW; Kleer CG; Sabel MS; Griffith KA; Teknos TN; Merajver SD
    Cancer Res; 2005 Sep; 65(18):8366-71. PubMed ID: 16166314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.
    Orazine CI; Hincapie M; Hancock WS; Hattersley M; Hanke JH
    J Proteome Res; 2008 Apr; 7(4):1542-54. PubMed ID: 18336003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of nipple aspirate fluid for diagnosis of breast cancer: an alternative to invasive biopsy.
    Sauter ER
    Expert Rev Mol Diagn; 2005 Nov; 5(6):873-81. PubMed ID: 16255629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics research in breast cancer: balancing discovery and hypothesis-driven studies.
    Veenstra TD
    Expert Rev Proteomics; 2011 Apr; 8(2):139-41. PubMed ID: 21501004
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.
    Rose AA; Grosset AA; Dong Z; Russo C; Macdonald PA; Bertos NR; St-Pierre Y; Simantov R; Hallett M; Park M; Gaboury L; Siegel PM
    Clin Cancer Res; 2010 Apr; 16(7):2147-56. PubMed ID: 20215530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the molecular biology of inflammatory breast cancer.
    Charafe-Jauffret E; Tarpin C; Viens P; Bertucci F
    Semin Oncol; 2008 Feb; 35(1):41-50. PubMed ID: 18308145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p95HER2 and breast cancer.
    Arribas J; Baselga J; Pedersen K; Parra-Palau JL
    Cancer Res; 2011 Mar; 71(5):1515-9. PubMed ID: 21343397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Z-dependent protease inhibitor (ZPI) is present in loco in human breast cancer tissue.
    Sierko E; Wojtukiewicz MZ; Ostrowska-Cichocka K; Zimnoch L
    Thromb Haemost; 2010 Jul; 104(1):183-5. PubMed ID: 20458435
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation of the multiplex ligation-dependent probe amplification (MLPA) technique for the determination of HER2 gene amplification in breast cancer.
    Farshid G; Cheetham G; Davies R; Moore S; Rudzki Z
    Diagn Mol Pathol; 2011 Mar; 20(1):11-7. PubMed ID: 21326034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone-breaking cancer treatment.
    Roodman GD
    Nat Med; 2007 Jan; 13(1):25-6. PubMed ID: 17206127
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomarkers in breast cancer.
    Vivanco Md
    Methods Mol Biol; 2010; 593():137-56. PubMed ID: 19957148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of gene expression profile signatures in early-stage breast cancer.
    Desmedt C; Sotiriou C; Piccart-Gebhart MJ
    Cancer Invest; 2009 Jan; 27(1):1-10. PubMed ID: 19191098
    [No Abstract]   [Full Text] [Related]  

  • 18. Heading in a new direction: drug permeability in breast cancer brain metastasis.
    Sledge GW
    Clin Cancer Res; 2010 Dec; 16(23):5605-7. PubMed ID: 21045085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance.
    Besada V; Diaz M; Becker M; Ramos Y; Castellanos-Serra L; Fichtner I
    Proteomics; 2006 Feb; 6(3):1038-48. PubMed ID: 16385476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
    Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
    Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.